Reducible PEG-POD/DNA Nanoparticles for Gene Transfer In Vitro and In Vivo: Application in a Mouse Model of Age-Related Macular Degeneration
Non-viral gene delivery systems are being developed to address limitations of viral gene delivery. Many of these non-viral systems are modeled on the properties of viruses including cell surface binding, endocytosis, endosomal escape, and nuclear targeting. Most non-viral gene transfer systems exhib...
Main Authors: | Bhanu Chandar Dasari, Siobhan M. Cashman, Rajendra Kumar-Singh |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-09-01
|
Series: | Molecular Therapy: Nucleic Acids |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253117301877 |
Similar Items
-
Extended duration of transgene expression from pegylated POD nanoparticles enables attenuation of photoreceptor degeneration.
by: Christina Binder, et al.
Published: (2013-01-01) -
A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration.
by: Siobhan M Cashman, et al.
Published: (2011-04-01) -
Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina
by: Singh Brij B, et al.
Published: (2011-08-01) -
PEG Conjugated Zein Nanoparticles for In Vivo Use
by: Courtney van Ballegooie, et al.
Published: (2022-08-01) -
Targeting Tissue Lipids in Age-related Macular Degeneration
by: Rajendra S. Apte
Published: (2016-03-01)